Canonical ingredient
1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-
INDOMETHACIN
34 linked products
Official identifiers
Names and synonyms
- 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (en)
- Indométhacine (fr)
- Indométacine (fr-CA)
Source-scoped chemical properties
Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.
- canada dsl listing
- listed
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl bioaccumulative
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl inherently toxic aquatic
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets cepa categorization
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets environmental
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl meets human health
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl persistent
- No
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
- dsl substance category
- Organics
- canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03 Official record ↗
Equivalent concepts in other registries
These links require an exact shared identifier; names alone are never sufficient.
- indometacin
GLOBAL · CAS 53-86-1
Verification source
Safety and technical documents
General references and manufacturer-specific SDS documents are kept separate.
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.
End-to-end traceability
Only links supported by an identified source are published. Missing evidence remains explicitly unknown.
Evidence still missing
- Country or region of origin
- Raw-material producer
- Ingredient manufacturer
- Distributor
- Transformation steps
Documented origins
No origin has been proven yet by an explicit source.
Documented organizations
No organization has been proven yet by an explicit source.
Documented transformations
No transformation step has been proven yet by an explicit source.
Method: a company’s registration country is never used as evidence of a material’s origin.
Products containing this ingredient
APO-INDOMETHACIN
25 · MG
APO-INDOMETHACIN
50 · MG
AURO-INDOMETHACIN
50 · MG
FTP-INDOMETHACIN
25 · MG · CAP
FTP-INDOMETHACIN
50 · MG · CAP
INDOCID CAP 25MG
25 · MG · CAP
INDOCID CAP 50MG
50 · MG · CAP
INDOCID SR 75MG
75 · MG · CAP
INDOCID STERILE OPH SUSP 1%
10 · MG · ML
INDOCID SUP 100MG
100 · MG · SUP
INDOCID SUP 50MG
50 · MG · SUP
INDOCOLLYRE
1 · MG · 1 · ML
MINT-INDOMETHACIN
50 · MG
MINT-INDOMETHACIN
25 · MG
NOVO-METHACIN - 100MG SUP
100 · MG · SUP
NOVO-METHACIN - SUP 50MG
50 · MG · SUP
NTP-INDOMETHACIN
25 · MG
NTP-INDOMETHACIN
50 · MG
NU-INDO CAP 25MG
25 · MG
NU-INDO CAP 50MG
50 · MG
ODAN-INDOMETHACIN
50 · MG · SUP
ODAN-INDOMETHACIN
100 · MG · SUP
PRO-INDO 25 CAP 25MG
25 · MG
PRO-INDO 50 CAP 50MG
50 · MG
RATIO-INDOMETHACIN
100 · MG
RATIO-INDOMETHACIN
50 · MG
RATIO-INDOMETHACIN
25 · MG
RATIO-INDOMETHACIN
50 · MG
RHODACINE - CAP 25MG
25 · MG · CAP
RHODACINE - CAP 50MG
50 · MG · CAP
RHODACINE - SUP 100MG
100 · MG
RHODACINE - SUP 50MG
50 · MG · SUP
TEVA-INDOMETHACIN
25 · MG
TEVA-INDOMETHACIN
50 · MG